"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ASND. [ FAQ on what and how to ask] For non-ASND questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Jan Moller Mikkelsen
Headquarter: Tuborg Boulevard 12, Hellerup, Denmark, 2900
Industry: Biotechnology, Investment Track: antibody-based products, Employees: 1,189
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
My Watchlist
